Global Gastroparesis Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Gastroparesis drugs are medications designed to manage the symptoms and complications of gastroparesis, a condition characterized by delayed emptying of the stomach, leading to symptoms such as nausea, vomiting, abdominal pain, and a feeling of fullness. The primary goal of these drugs is to regulate and improve stomach motility, helping to move food through the digestive system more efficiently. Prokinetic agents, such as metoclopramide and domperidone, are commonly prescribed to stimulate stomach contractions and facilitate gastric emptying. Additionally, antiemetic drugs may be prescribed to alleviate nausea and vomiting associated with gastroparesis. While there is no cure for gastroparesis, these medications aim to provide symptomatic relief and improve the overall quality of life for individuals affected by this gastrointestinal disorder. Treatment plans may also include dietary modifications, lifestyle changes, and in severe cases, surgical interventions to manage the condition effectively.

According to DIResearch's in-depth investigation and research, the global Gastroparesis Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Hanmi Pharm, Kyowa Kirin Pharmaceuticals, Ani Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Gastroparesis Drugs. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastroparesis Drugs market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gastroparesis Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastroparesis Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Gastroparesis Drugs Include:

Sumitomo

Cadila Pharmaceuticals

Sanofi

Teva

Johnson & Johnson

Pfizer

Hanmi Pharm

Kyowa Kirin Pharmaceuticals

Ani Pharmaceuticals

Gastroparesis Drugs Product Segment Include:

Prokinetic Agents

Antiemetic Agents

Others

Gastroparesis Drugs Product Application Include:

Diabetic Gastroparesis

Idiopathic Gastroparesis

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Gastroparesis Drugs Industry PESTEL Analysis

Chapter 3: Global Gastroparesis Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Gastroparesis Drugs Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Gastroparesis Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Gastroparesis Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Gastroparesis Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Gastroparesis Drugs Product by Type

1.2.1 Global Gastroparesis Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Prokinetic Agents

1.2.3 Antiemetic Agents

1.2.4 Others

1.3 Gastroparesis Drugs Product by Application

1.3.1 Global Gastroparesis Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Diabetic Gastroparesis

1.3.3 Idiopathic Gastroparesis

1.4 Global Gastroparesis Drugs Market Revenue and Sales Analysis

1.4.1 Global Gastroparesis Drugs Market Size Analysis (2019-2030)

1.4.2 Global Gastroparesis Drugs Market Sales Analysis (2019-2030)

1.4.3 Global Gastroparesis Drugs Market Sales Price Trend Analysis (2019-2030)

1.5 Gastroparesis Drugs Market Development Status and Trends

1.5.1 Gastroparesis Drugs Industry Development Status Analysis

1.5.2 Gastroparesis Drugs Industry Development Trends Analysis

2 Gastroparesis Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Gastroparesis Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Gastroparesis Drugs Market Analysis by Regions

4.1 Gastroparesis Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Gastroparesis Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Gastroparesis Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Gastroparesis Drugs Revenue Forecast by Region (2025-2030)

4.3 Global Gastroparesis Drugs Sales and Forecast Analysis (2019-2030)

4.3.1 Global Gastroparesis Drugs Sales and Market Share by Region (2019-2024)

4.3.2 Global Gastroparesis Drugs Sales Forecast by Region (2025-2030)

4.4 Global Gastroparesis Drugs Sales Price Trend Analysis (2019-2030)

5 Global Gastroparesis Drugs Market Size by Type and Application

5.1 Global Gastroparesis Drugs Market Size by Type

5.1.1 Global Gastroparesis Drugs Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Gastroparesis Drugs Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Gastroparesis Drugs Market Size by Application

5.2.1 Global Gastroparesis Drugs Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Gastroparesis Drugs Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Gastroparesis Drugs Market Size by Type

6.3.1 North America Gastroparesis Drugs Sales by Type (2019-2030)

6.3.2 North America Gastroparesis Drugs Revenue by Type (2019-2030)

6.4 North America Gastroparesis Drugs Market Size by Application

6.4.1 North America Gastroparesis Drugs Sales by Application (2019-2030)

6.4.2 North America Gastroparesis Drugs Revenue by Application (2019-2030)

6.5 North America Gastroparesis Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Gastroparesis Drugs Market Size by Type

7.3.1 Europe Gastroparesis Drugs Sales by Type (2019-2030)

7.3.2 Europe Gastroparesis Drugs Revenue by Type (2019-2030)

7.4 Europe Gastroparesis Drugs Market Size by Application

7.4.1 Europe Gastroparesis Drugs Sales by Application (2019-2030)

7.4.2 ? Europe Gastroparesis Drugs Revenue by Application (2019-2030)

7.5 Europe Gastroparesis Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Gastroparesis Drugs Market Size by Type

8.3.1 China Gastroparesis Drugs Sales by Type (2019-2030)

8.3.2 China Gastroparesis Drugs Revenue by Type (2019-2030)

8.4 China Gastroparesis Drugs Market Size by Application

8.4.1 China Gastroparesis Drugs Sales by Application (2019-2030)

8.4.2 China Gastroparesis Drugs Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Gastroparesis Drugs Market Size by Type

9.3.1 APAC (excl. China) Gastroparesis Drugs Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Gastroparesis Drugs Revenue by Type (2019-2030)

9.4 APAC (excl. China) Gastroparesis Drugs Market Size by Application

9.4.1 APAC (excl. China) Gastroparesis Drugs Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Gastroparesis Drugs Revenue by Application (2019-2030)

9.5 APAC (excl. China) Gastroparesis Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Gastroparesis Drugs Market Size by Type

10.3.1 Latin America Gastroparesis Drugs Sales by Type (2019-2030)

10.3.2 Latin America Gastroparesis Drugs Revenue by Type (2019-2030)

10.4 Latin America Gastroparesis Drugs Market Size by Application

10.4.1 Latin America Gastroparesis Drugs Sales by Application (2019-2030)

10.4.2 Latin America Gastroparesis Drugs Revenue by Application (2019-2030)

10.5 Latin America Gastroparesis Drugs Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Gastroparesis Drugs Market Size by Type

11.3.1 Middle East & Africa Gastroparesis Drugs Sales by Type (2019-2030)

11.3.2 Middle East & Africa Gastroparesis Drugs Revenue by Type (2019-2030)

11.4 Middle East & Africa Gastroparesis Drugs Market Size by Application

11.4.1 Middle East & Africa Gastroparesis Drugs Sales by Application (2019-2030)

11.4.2 Middle East & Africa Gastroparesis Drugs Revenue by Application (2019-2030)

11.5 Middle East & Africa Gastroparesis Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Gastroparesis Drugs Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Gastroparesis Drugs Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Gastroparesis Drugs Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Gastroparesis Drugs Average Sales Price by Manufacturers (2020-2024)

12.2 Gastroparesis Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Gastroparesis Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sumitomo

13.1.1 Sumitomo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sumitomo Gastroparesis Drugs Product Portfolio

13.1.3 Sumitomo Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Cadila Pharmaceuticals

13.2.1 Cadila Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio

13.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Sanofi

13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Sanofi Gastroparesis Drugs Product Portfolio

13.3.3 Sanofi Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Teva

13.4.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Teva Gastroparesis Drugs Product Portfolio

13.4.3 Teva Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Johnson & Johnson

13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Johnson & Johnson Gastroparesis Drugs Product Portfolio

13.5.3 Johnson & Johnson Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Pfizer

13.6.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Pfizer Gastroparesis Drugs Product Portfolio

13.6.3 Pfizer Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Hanmi Pharm

13.7.1 Hanmi Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Hanmi Pharm Gastroparesis Drugs Product Portfolio

13.7.3 Hanmi Pharm Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Kyowa Kirin Pharmaceuticals

13.8.1 Kyowa Kirin Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio

13.8.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Ani Pharmaceuticals

13.9.1 Ani Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio

13.9.3 Ani Pharmaceuticals Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Gastroparesis Drugs Industry Chain Analysis

14.2 Gastroparesis Drugs Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Gastroparesis Drugs Typical Downstream Customers

14.4 Gastroparesis Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support